I have to say, I bought this stock for the long term. I reckon it will be a money spinner for decades - and we won't own it. Hopefully transurban will pay a little more for it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025